Restoration of proper trafficking to the cell surface for membrane proteins harboring cysteine mutations

Angelica Lopez-Rodriguez1, Miguel Holmgren

  • 1Neurophysiology Section, Porter Neuroscience Research Center, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, Maryland, USA.

Plos One
|October 20, 2012
PubMed

Insights

Genetic mutations in cysteine can cause severe color blindness by preventing membrane proteins from reaching the cell surface. Chemical modification of these cysteine mutants restored protein delivery and function.

Area of Science:

  • Molecular Biology
  • Genetics
  • Neuroscience

Background:

  • Genetic diseases often manifest as impaired cell surface delivery of full-length membrane proteins.
  • Single point mutations in cysteine are implicated in various conditions, including autism, hereditary spherocytosis, and color blindness.

Purpose of the Study:

  • To investigate two inheritable cysteine mutants of cyclic nucleotide-gated channels responsible for achromatopsia, a severe form of color blindness.
  • To explore a novel strategy for correcting membrane protein trafficking defects by leveraging cysteine's chemical properties.

Main Methods:

  • Studied two specific cysteine mutants of cyclic nucleotide-gated channels linked to achromatopsia.
  • Utilized chemical reagents to modify the sulfhydryl group of cysteine residues in the mutants.
  • Attached moieties with chemistries similar to wild-type amino acid side chains.

Main Results:

  • Chemical modifications successfully restored the proper delivery of mutant channels to the cell membrane.
  • The corrected channels demonstrated normal functional properties once localized at the cell surface.
  • This approach offers a potential method for diagnosing membrane protein traffic issues.

Conclusions:

  • Targeting cysteine's reactivity can correct genetic defects in membrane protein trafficking.
  • This strategy shows promise for treating conditions arising from protein delivery problems.
  • The findings provide a new avenue for understanding and potentially addressing genetic disorders affecting membrane proteins.

Related Concept Videos

Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
ER Retrieval Pathway01:45

ER Retrieval Pathway

In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...